Inventor · disambiguated record
Albert Jean Robichaud
Also filed as: RAJAGOPALAN PARTHASARATHI · ROBICHAUD ALBERT · ROBICHAUD ALBERT J · ROBICHAUD ALBERT JEAN
111 granted patents·79 pending applications·2,917 citations·filing 1992–2025
99Inventor score
Files withSAGE THERAPEUTICS INC124WYETH CORP24BRISTOL MYERS SQUIBB PHARMA CO10WYETH LLC10UNIV WASHINGTON6
Top patents by PatentIndex Score
190 records- 0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
- 0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
- 0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
- 0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
- 0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
- 0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
- 0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
- 0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
- 0998US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
- 1098US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
- 1198US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
- 1298US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
- 1398US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
- 1498US10696712B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·21 cites·3 claims
- 1598US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
- 1698US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
- 1798US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
- 1898US7238690B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jul 3, 2007·127 cites·4 claims
- 1998US7183282B2Substituted heterocycle fused γ-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Feb 27, 2007·145 cites·4 claims
- 2098US6849619B2Substituted pyridoindoles as serotonin agonists and antagonistsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 1, 2005·119 cites·26 claims
- 2198US6552017B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 22, 2003·208 cites·21 claims
- 2297US12060386B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·3 cites·10 claims
- 2397US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
- 2497US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
- 2597US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
- 2697US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
- 2797US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
- 2897US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
- 2997US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
- 3097US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
- 3197US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
- 3297US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
- 3397US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
- 3497US10201550B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·23 cites·2 claims
- 3597US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
- 3697US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
- 3797US9630986B2Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameUNIV WASHINGTON·Filed 2013·Granted Apr 25, 2017·49 cites·18 claims
- 3897US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
- 3997USRE39680ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·142 cites·21 claims
- 4097USRE39679ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·129 cites·33 claims
- 4197US7081455B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 25, 2006·115 cites·17 claims
- 4297US7071186B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jul 4, 2006·121 cites·15 claims
- 4397US6713471B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 30, 2004·172 cites·33 claims
- 4497US6548493B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·179 cites·23 claims
- 4596US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
- 4696US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
- 4796US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
- 4896US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
- 4996US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 5096US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
Showing the top 50 of 190 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Albert Jean Robichaud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →